LA JOLLA, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTCQB:MYDX), a rapidly growing chemical detection company and makers of MyDx®, the first handheld chemical analyzer for consumers, today announced it will present at two, high profile investor conferences this month: the Web Summit in Lisbon, Portugal to be held from November 7-10, and the World of Cannabis Summit in Las Vegas from November 15-16.
Additionally, MyDx Chairman and Chief Executive Officer Daniel R. Yazbeck will be attending the ArcView Group meeting November 14-15 in Las Vegas. ArcView is the legal cannabis industry's premier hub for investment, data and progress. Mr. Yazbeck is being featured in the new 2016 Cannabis Investor Study co-published and co-produced by ArcView Market Research and New Frontier Data. An investor member since 2013, he is one of only three cannabis company leaders featured with an “Entrepreneur Q&A” interview published in the 55-page Report.
“The Vote Heard Round the Word:” Cannabis Industry Anticipates November 8, Election
These upcoming events hold special importance as the cannabis industry is highly anticipating the November 8, vote in nine States with ballot initiatives to legalize cannabis in some regulatory form, five of whom including California are asking voters to approve recreational use.
The New York Times reports: “The market for both recreational and medicinal marijuana is projected to grow to $22 billion in four years from $7 billion this year if California says yes, according to projections by the ArcView Group, a company that links investors with cannabis companies.
“This is the vote heard round the world,” said ArcView’s chief executive, Troy Dayton. “What we’ve seen before has been tiny compared to what we are going to see in California.”
World of Cannabis Summit, Las Vegas
At the World of Cannabis Summit, MyDx will host a booth on the main exhibitor floor. Also, Mr. Yazbeck will present on the panel titled, “Funding your Business” on November 16, 2016 at 10:00 a.m. PST, where he will be joined by the other two panel members Keith McCarty, CEO and Founder of Eaze, offering a leading cannabis delivery service App which just raised $13 million in its Series B round, and Randy Shipley, President of MJIC, a leader in media and professional services in the cannabis industry.
There, Mr. Yazbeck will share his unique insights and expertise from his success leading MyDx from a crowdfunded startup to rapidly growing public company already nearing positive cash flow. For more information, visit: http://worldofcannabissummit.com/about/.
The Company last week announced it has launched its OrganaDx sensor chip. The Company’s CannaDxTM Sensor chip enables consumers to test, analyze and evaluate cannabis for potency and composition of psychoactive, and non-psychoactive medicinal, chemical components. Its newly launched OrganaDx sensor enables consumers to test cannabis for safety. The groundwater under any crop may be contaminated and many growers, both indoor and outdoor, use pesticides or fertilizers that contain dangerous toxins as the media routinely confirms.
Web Summit, Lisbon, Portugal: “Europe’s Largest Technology Marketplace”
Known as “Europe’s Largest Technology Marketplace,” the Web Summit is “home to many independent conferences” (https://websummit.net/). This event provides MyDx a unique opportunity to introduce its growing product line directly to a wide range of prospective partners and customers at the highest levels of industry and technology worldwide.
With over 50,000 tech CEOs, founders, startups, investors and political leaders already booked, a sampling of attending global brand luminaries includes: Facebook CMO Gary Briggs, Groupon CEO Rich Williams, Spotify CMO Seth Farbman, Forbes President Mike Perlis, Burning Man Project Founding Board Member Marian Goodell, Tinder Co-Founder and CEO Sean Rad, and Google Ventures General Partner Tom Hulme. Cannabis Industry attendees include Merry Jane & Stampede Founder and CEO Ted Chung, and Privateer Holdings CEO Brendan Kenney. For a complete list of featured attendees, visit https://websummit.net/speakers. Media covering this event include The Guardian, CNN Money, Bloomberg, Tech Crunch, Time Magazine, Wired Magazine and many others.
MyDx will host a booth in a Web Summit exhibitor hall throughout the conference. MyDx was also selected as 1 of 45 companies (1500+ startups attending) by an Independent Panel of IoT and Hardware Specialists to demonstrate its multi-purpose Analyzer, with smart phone app and its growing line of sensors, to a live audience of key global brands on the Web Summit Machine Demo Stage on Thursday, November 10 at 1:15 p.m. GMT.
MyDx: Brand Building at the Global Level
At all three conferences, a member of the MyDx team will be available to meet with institutional investors and industry leaders interested in collaborating on global distribution, marketing and other strategic ventures. To schedule a meeting, please contact Phillip Sugarman at Investor Relations Partners, the Company’s IR counsel of record, at 818-280-6800.
About MyDx, Inc.
MyDx, Inc. (OTCQB:MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology.
The MyDx CannaDxTM AquaDxTM and OrganaDxTM Sensors are now commercialized, and the AeroDxTM application is next in line. All Sensors will be compatible with a MyDx App that empowers consumers to test the chemical composition of what they eat, drink and inhale. For more information, please visit www.cdxlife.com.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.
Last updated on: 01/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.